Literature DB >> 9316972

Nitric oxide produced by inducible nitric oxide synthase delays gastric emptying in lipopolysaccharide-treated rats.

K Takakura1, K Hasegawa, Y Goto, I Muramatsu.   

Abstract

BACKGROUND: Endotoxin induces nitric oxide synthase (NOS), resulting in relaxation of gastric smooth muscle. The authors examined the effect of NO produced in response to lipopolysaccharide (LPS) treatment on gastric emptying in rats, and they also examined the effects of a selective inhibitor of inducible NOS (iNOS), aminoguanidine, and a suppressor of iNOS gene expression, dexamethasone.
METHODS: Male Wistar rats weighing 200-250 g were used. LPS-treated rats received LPS (0.2-10 mg/kg) diluted in physiologic saline intraperitoneally. Before and at different intervals up to 8 h after administration of LPS, measurements of gastric emptying were performed in groups of 3-5 rats, by determining the amount of phenol red remaining in the stomach 20 min after intragastric instillation. In additional group of LPS (2 mg/kg)-treated rats, the gastric fundus was isolated 6 h after administration, and the tension changes in response to L-arginine, a substrate for NOS, and electrical transmural stimulation (3 Hz, 5 s) were recorded isometrically.
RESULTS: (1) Gastric emptying was delayed by pretreatment with LPS in a dose- and time-dependent fashion (reduction from 68 +/- 12% to 22 +/- 7% with a dose of 2 mg/kg for 6 h). Aminoguanidine (50 mg/kg) or dexamethasone (5 mg/kg) partially inhibited the delay (to 39 +/- 4% or to 40 +/- 10%, respectively). (2) L-arginine (0.1 mM) produced a relaxation (28 +/- 2% reduction in active tension) in the gastric fundus strips isolated from LPS-treated rats but not from LPS-untreated rats. The relaxation was inhibited by aminoguanidine (1 mM). In contrast, the relaxation response to the electrical stimulation was not affected by aminoguanidine (0.1-1 mM).
CONCLUSION: The present study suggests that NO, probably produced by iNOS, is one of the factors involved in the delay of gastric emptying in the LPS-treated rats and probably in those with sepsis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316972     DOI: 10.1097/00000542-199709000-00027

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  10 in total

1.  Effect of lipopolysaccharide on diarrhea and gastrointestinal transit in mice: roles of nitric oxide and prostaglandin E2.

Authors:  Yu-Chih Liang; Hung-Jung Liu; Sheng-Hsuan Chen; Chun-Chin Chen; Liang-Shung Chou; Li Hsueh Tsai
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

2.  Mechanisms involved in protection afforded by L-arginine in ibuprofen-induced gastric damage: role of nitric oxide and prostaglandins.

Authors:  Dolores Jiménez; M José Martin; David Pozo; Catalina Alarcón; José Esteban; Leo Bruseghini; Antonio Esteras; Virginia Motilva
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

3.  The impact of admission diagnosis on gastric emptying in critically ill patients.

Authors:  Nam Q Nguyen; Mei P Ng; Marianne Chapman; Robert J Fraser; Richard H Holloway
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

4.  Involvement of serotonin and nitric oxide in endotoxin-induced gastric motility changes in conscious rats.

Authors:  Toshio Watanabe; Takeshi Tomomasa; Hiroaki Kaneko; Atsushi Takahashi; Masahiko Tabata; Sarwar Hussain; Akihiro Morikawa
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

5.  IL-1 receptor antagonist blocks the lipopolysaccharide-induced inhibition of gastric motility in freely moving conscious rats.

Authors:  Yoshihiro Tsuchiya; Tsukasa Nozu; Shima Kumei; Masumi Ohhira; Toshikatsu Okumura
Journal:  Dig Dis Sci       Date:  2012-05-19       Impact factor: 3.199

6.  A conscious mouse model of gastric ileus using clinically relevant endpoints.

Authors:  Matthew A Firpo; Michael D Rollins; Aniko Szabo; Justin D Gull; Jeffrey D Jackson; Yuanlin Shao; Robert E Glasgow; Sean J Mulvihill
Journal:  BMC Gastroenterol       Date:  2005-06-06       Impact factor: 3.067

7.  Lipopolysaccharide reduces food passage rate from the crop by a prostaglandin-independent mechanism in chickens.

Authors:  T Tachibana; M Ogino; R Makino; M S I Khan; M A Cline
Journal:  Br Poult Sci       Date:  2016-12-02       Impact factor: 2.095

8.  Novel Ex Vivo Model to Examine the Mechanism and Relationship of Esophageal Microbiota and Disease.

Authors:  Samuel Cass; Catherine Hamilton; Aaron Miller; Daniel Jupiter; Kamil Khanipov; Adam Booth; Richard Pyles; Timothy Krill; Gabriel Reep; Ikenna Okereke
Journal:  Biomedicines       Date:  2021-02-02

9.  Prolonged lipopolysaccharide-induced illness elevates glucagon-like peptide-1 and suppresses peptide YY: A human-randomized cross-over trial.

Authors:  Katrine Brodersen; Maike Mose; Ulla Ramer Mikkelsen; Jens Otto Lunde Jørgensen; Michael Festersen Nielsen; Niels Møller; Anne-Marie Wegeberg; Christina Brock; Bolette Hartmann; Jens Juul Holst; Nikolaj Rittig
Journal:  Physiol Rep       Date:  2022-09

10.  Antioxidant activity of inulin and its role in the prevention of human colonic muscle cell impairment induced by lipopolysaccharide mucosal exposure.

Authors:  Valentina Pasqualetti; Annamaria Altomare; Michele Pier Luca Guarino; Vittoria Locato; Silvia Cocca; Sara Cimini; Rossella Palma; Rossana Alloni; Laura De Gara; Michele Cicala
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.